These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7677074)

  • 1. Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction.
    Maynard C; Weaver WD; Lambrew C; Bowlby LJ; Rogers WJ; Rubison RM
    Am J Cardiol; 1995 Sep; 76(8):548-52. PubMed ID: 7677074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1.
    Lambrew CT; Bowlby LJ; Rogers WJ; Chandra NC; Weaver WD
    Arch Intern Med; 1997 Dec 8-22; 157(22):2577-82. PubMed ID: 9531226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.
    Rogers WJ; Bowlby LJ; Chandra NC; French WJ; Gore JM; Lambrew CT; Rubison RM; Tiefenbrunn AJ; Weaver WD
    Circulation; 1994 Oct; 90(4):2103-14. PubMed ID: 7923698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction).
    Goldberg RJ; Mooradd M; Gurwitz JH; Rogers WJ; French WJ; Barron HV; Gore JM
    Am J Cardiol; 1998 Aug; 82(3):259-64. PubMed ID: 9708650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Alabama Registry of Myocardial Ischemia Investigators.
    Rogers WJ; Dean LS; Moore PB; Wool KJ; Burgard SL; Bradley EL
    Am J Cardiol; 1994 Jul; 74(2):111-8. PubMed ID: 8023773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Western Washington Myocardial Infarction Registry and Emergency Department Tissue Plasminogen Activator Treatment Trial.
    Althouse R; Maynard C; Cerqueira MD; Olsufka M; Ritchie JL; Kennedy JW
    Am J Cardiol; 1990 Dec; 66(19):1298-303. PubMed ID: 2123073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in coronary thrombolytic therapy for acute myocardial infarction (the Minnesota Heart Survey Registry, 1990 to 1993).
    Rosamond WD; Shahar E; McGovern PG; Sides TL; Luepker RV
    Am J Cardiol; 1996 Aug; 78(3):271-7. PubMed ID: 8759803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays in thrombolytic therapy for acute myocardial infarction in Finland. Results of a national thrombolytic therapy delay study. Finnish Hospitals' Thrombolysis Survey Group.
    Hirvonen TP; Halinen MO; Kala RA; Olkinuora JT
    Eur Heart J; 1998 Jun; 19(6):885-92. PubMed ID: 9651712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction.
    Gurwitz JH; Gore JM; Goldberg RJ; Rubison M; Chandra N; Rogers WJ
    Ann Intern Med; 1996 Feb; 124(3):283-91. PubMed ID: 8554222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators.
    Canto JG; Every NR; Magid DJ; Rogers WJ; Malmgren JA; Frederick PD; French WJ; Tiefenbrunn AJ; Misra VK; Kiefe CI; Barron HV
    N Engl J Med; 2000 May; 342(21):1573-80. PubMed ID: 10824077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The thrombolytic treatment of acute myocardial infarct in an emergency department].
    Torrado González E; Ferriz Martín JA; Vera Almazán A; Alvarez Bueno M; Rodríguez García JJ; González Rodríguez-Villasonte P; López Vargas C; García Paredes T
    Rev Esp Cardiol; 1997 Oct; 50(10):689-95. PubMed ID: 9417558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic delay and reduced functional status six months after thrombolysis for acute myocardial infarction.
    Avorn J; Knight E; Ganz DA; Schneeweiss S
    Am J Cardiol; 2004 Aug; 94(4):415-20. PubMed ID: 15325921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital delays and problems with thrombolytic administration in patients receiving thrombolytic therapy: a multicenter prospective assessment. Virginia Thrombolytic Study Group.
    Gonzalez ER; Jones LA; Ornato JP; Bleecker GC; Strauss MJ
    Ann Emerg Med; 1992 Oct; 21(10):1215-21. PubMed ID: 1416300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction. Canadian GUSTO Investigators. Global Utilization of Streptokinase and + PA for Occluded Coronary Arteries.
    Cox JL; Lee E; Langer A; Armstrong PW; Naylor CD
    CMAJ; 1997 Feb; 156(4):497-505. PubMed ID: 9054819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2).
    Peterson LR; Chandra NC; French WJ; Rogers WJ; Weaver WD; Tiefenbrunn AJ
    Am J Cardiol; 1999 Dec; 84(11):1287-91. PubMed ID: 10614792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Starting thrombolytic therapy for patients with acute myocardial infarction in Accident and Emergency Department: from implementation to evaluation.
    Chan WK; Lam KN; Lau FL; Tang HM
    Chin Med J (Engl); 1998 Apr; 111(4):291-4. PubMed ID: 10374389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
    Zeymer U; Schröder R; Machnig T; Neuhaus KL
    Am Heart J; 2003 Oct; 146(4):686-91. PubMed ID: 14564324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the site of delivery of thrombolytic treatment for acute myocardial infarction from the coronary care unit to the emergency department greatly reduces door to needle time.
    Hourigan CT; Mountain D; Langton PE; Jacobs IG; Rogers IR; Jelinek GA; Thompson PL
    Heart; 2000 Aug; 84(2):157-63. PubMed ID: 10908251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.